LYNNEA SKIMAN: Open Payments
NPI 1205571007 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,610 in 72 payments from 31 companies in 2025. Trend: 2023 $352 · 2024 $2,028 · 2025 $2,610
Food & beverage: $2,254Education: $356
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $212 |
| Incyte Corporation | 6 | $196 |
| Karyopharm Therapeutics Inc. | 4 | $196 |
| SOBI, INC | 5 | $195 |
| Merck Sharp & Dohme LLC | 5 | $156 |
| Regeneron Healthcare Solutions, Inc. | 2 | $130 |
| BeiGene USA, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $121 |
| Celgene Corporation | 4 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $106 |
Products named: XPOVIO, ERLEADA, BRUKINSA, KEYTRUDA, Trodelvy, LYNOZYFIC, Nubeqa, Vonjo.
Industry payments across NC — which companies pay providers there.
